Xylometazoline
Specifications
526-36-3CAS Number
208-390-6EC Number
2-[(4-tert-butyl-2,6-dimethylphenyl)methyl]-4,5-dihydro-1H-imidazoleIUPAC Name
C16H24N2Chemical Formula
244.37 g/molMolecular Weight
xylometazoline; 526-36-3; Xylomethazoline; Otriven; 2-[(4-tert-butyl-2,6-dimethylphenyl)methyl]-4,5-dihydro-1H-imidazole; Xilometazolina; Xylometazolinum; Balminil; WPY40FTH8K; 2-(4-tert-Butyl-2,6-dimethylbenzyl)-2-imidazoline; 1H-Imidazole, 2-((4-(1,1-dimethylethyl)-2,6-dimethylphenyl)methyl)-4,5-dihydro-; DTXSID8046957; 1H-Imidazole, 2-[[4-(1,1-dimethylethyl)-2,6-dimethylphenyl]methyl]-4,5-dihydro-; stas; Nasan; Otrivin Mentol; Nasentropfen AL; Nasenspray AL; 2-((4-tert-butyl-2,6-dimethylphenyl)methyl)-4,5-dihydro-1H-imidazole; NasenSpray ratiopharm; NasenTropfen ratiopharm; RefChem:58081; DTXCID6026957; 2-(4'-tert-butyl-2',6'-dimethylphenylmethyl)imidazoline; R01AA07; R01AB06; S01GA03; 208-390-6; Otrivin; Otrix; 2-(4-(tert-butyl)-2,6-dimethylbenzyl)-4,5-dihydro-1H-imidazole; Ba-11391; CHEMBL312448; 2-IMIDAZOLINE, 2-(4-tert-BUTYL-2,6-DIMETHYLBENZYL)-; Ba 11391; Otriven; Otrivin; Xylometazoline (INN); XYLOMETAZOLINE [INN]; F1371-0282; 2-{[4-(tert-butyl)-2,6-dimethylphenyl]methyl}-2-imidazoline; Xylometazoline [INN:BAN]; Xylometazolinum [INN-Latin]; Xilometazolina [INN-Spanish]; NCGC00016101-02; EINECS 208-390-6; UNII-WPY40FTH8K; Ba 11391; CAS-1218-35-5; BRN 0180524; Balminil (TN); Spectrum_000382; Prestwick0_000223; Prestwick1_000223; Prestwick2_000223; Prestwick3_000223; Spectrum2_000945; Spectrum3_000586; Spectrum4_000382; Spectrum5_001469; Lopac-X-6000; XYLOMETAZOLINE [MI]; 2-[[4-(1,1-Dimethylethyl)-2,6-dimethylphenyl]methyl]-4,5-dihydro-1H-imidazole; Lopac0_001269; SCHEMBL34087; BSPBio_000265; BSPBio_002032; GTPL517; KBioGR_000903; KBioSS_000862; 5-23-07-00109 (Beilstein Handbook Reference); DivK1c_000158; XYLOMETAZOLINE [VANDF]; SPBio_000910; SPBio_002186; BPBio1_000293; XYLOMETAZOLINE [WHO-DD]; BDBM30703; CHEBI:10082; cid_5282386; HY-B0475A; KBio1_000158; KBio2_000862; KBio2_003430; KBio2_005998; KBio3_001532; NINDS_000158; HMS3604M22; HMS5085B13; SMSSF-0040298; 2-(4-tert-Butyl-2,6-dimethylbenzyl)-4,5-dihydro-1H-imidazole; EBC-26296; MFCD00242956; s5854; SBB038185; STK558658; 2-[(4-tert-butyl-2,6-dimethyl-phenyl)methyl]-4,5-dihydro-1H-imidazole; AKOS000115430; CCG-205342; DB06694; KS-5071; SDCCGSBI-0051235.P004; IDI1_000158; C4X-17232Oxymetazoline EP Impurity B; NCGC00016101-01; NCGC00016101-03; NCGC00016101-04; NCGC00016101-05; NCGC00016101-06; NCGC00016101-07; NCGC00016101-09; NCGC00016101-12; NCGC00016101-15; NCGC00016101-18; NCGC00024281-03; ST024781; SBI-0051235.P003; DB-052151; CS-0013861; NS00000479; EN300-02385; VU0239751-6; C07913; D08684; G78137; Q31030; AB00053567_11; AB00053567_12; L001171; 2-[(4-tert-butyl-2,6-xylyl)methyl]-2-imidazoline; BRD-K08356259-003-05-6; BRD-K08356259-003-15-5; BRD-K08356259-003-23-9; BRD-K08356259-003-24-7; 2-(4-tert-butyl-2,6-dimethyl-benzyl)-2-imidazoline;hydrochloride; 2-(4-tert-Butyl-2,6-dimethylbenzyl)-4,5-dihydro-1H-imidazole #; 2-[(4-t-butyl-2,6-dimethylphenyl)methyl]-4,5-dihydro-1H-imidazole; 2-[(4-t-butyl-2,6-dimethylphenyl)methyl]4,5dihydro-1H-imidazole; 2-[(4-tert-butyl-2,6-dimethyl-phenyl)methyl]-4,5-dihydro-1H-imidazole;hydrochloride; 2-[(4-tert-butyl-2,6-dimethylphenyl)methyl]-4,5-dihydro-1H-imidazole;hydrochlorideSynonyms
